Advancing breakthrough therapeutics through the purposeful integration of science and engineering. Backed by Lux.
About the role
You know clinical site budgets from the inside: how a protocol translates into procedures, how procedure-level benchmarks and institutional overheads differ by country, and where negotiations typically stall. You are comfortable holding a firm, well-reasoned position with a site while keeping the relationship intact, and you know when to escalate. You bring structure to complex, cross-functional study start up work and use data to shorten cycle times rather than just report on them.
What they're looking for
- Serve as the global subject-matter expert and accountable owner for investigator site and country budget development across assigned oncology studies
- Establish and govern global and country-specific budget templates, including benchmarking methodology, overhead and indirect-cost assumptions, and invoiceable-item conventions
- Develop, document, and maintain the FMV rationale for site budgets in an audit-ready manner, in alignment with anti-kickback, anti-bribery, and transparency requirements
- Lead budget and payment-term negotiations with investigator sites and institutions, directly on priority studies and sites and through oversight of CRO or vendor contracting teams
- Drive rapid, high-quality CTA execution to meet site activation targets across studies and countries
- Partner with Clinical Study Management and Study Start Up (SSU) leads to develop and execute study start up plans aligned with project timelines and site activation goals
More about this role
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.
About You
You know clinical site budgets from the inside: how a protocol translates into procedures, how procedure-level benchmarks and institutional overheads differ by country, and where negotiations typically stall. You are comfortable holding a firm, well-reasoned position with a site while keeping the relationship intact, and you know when to escalate. You bring structure to complex, cross-functional study start up work and use data to shorten cycle times rather than just report on them.
Position Overview
Eikon Therapeutics is seeking an Associate Director, Site Budgets & Contracts to join our Study Start Up group within Clinical Operations....
Browse similar: Startup jobs